Imunon, Inc. — Director's Dealing 2022

Jul 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2022-07-18

Reporting Person: Le Goff Corinne (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-18	Common Stock	A	53000	—	Acquired	53000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-18	Stock Option (Right to Buy)	$1.95	A	177000	Acquired	2032-07-18	Common Stock (177000)	Direct

Footnotes

F1: Represents grant of restricted stock which vests on July 18, 2023.

F2: Represents grant of stock option which vests with respect to 25% of the shares on July 18, 2023 and the remaining 75% percent in equal quarterly installments thereafter such that the stock option will be fully vested and exercisable on the fourth anniversary of July 18, 2026.